Privia Health Free Cash Flow 2020-2023 | PRVA

Privia Health free cash flow from 2020 to 2023. Free cash flow can be defined as a measure of financial performance calculated as operating cash flow minus capital expenditures.
Privia Health Annual Free Cash Flow
2023 80.67
2022 47.09
2021 54.51
2020 38.51
2019 18.65
Privia Health Quarterly Free Cash Flow
2023-12-31 80.67
2023-09-30 16.59
2023-06-30 -5.85
2023-03-31 -13.38
2022-12-31 47.09
2022-09-30 17.95
2022-06-30 1.82
2022-03-31 -5.35
2021-12-31 54.51
2021-09-30 66.98
2021-06-30 4.53
2021-03-31 -2.48
2020-12-31 38.51
2020-09-30 41.85
2020-06-30 6.31
2020-03-31 -7.09
2019-12-31
Sector Industry Market Cap Revenue
Medical Medical Information Systems $2.073B $1.658B
Privia Health Group Inc. is a technology-driven, physician enablement company which collaborates with medical groups, health plans and health systems to optimize physician practices, improve patient experiences and reward doctors for delivering high-value care in both in-person and virtual settings. Privia Health Group Inc. is based in Arlington, United States.
Stock Name Country Market Cap PE Ratio
GE HealthCare Technologies (GEHC) United States $37.389B 20.53
Inspire Medical Systems (INSP) United States $4.746B 0.00
Axonics (AXNX) United States $3.453B 0.00
10x Genomics (TXG) United States $3.145B 0.00
IRhythm Technologies (IRTC) United States $3.129B 0.00
Olink Holding AB (publ) (OLK) Sweden $2.985B 0.00
Hims & Hers Health (HIMS) United States $2.973B 0.00
Enovis (ENOV) United States $2.887B 21.40
Azenta (AZTA) United States $2.782B 156.36
Schrodinger (SDGR) United States $1.698B 0.00
Omnicell (OMCL) United States $1.372B 47.41
Phreesia (PHR) United States $1.370B 0.00
Standard BioTools (LAB) United States $0.734B 0.00
Fulgent Genetics (FLGT) United States $0.675B 0.00
Definitive Healthcare (DH) United States $0.657B 0.00
Talkspace (TALK) United States $0.489B 0.00
Clover Health Investments (CLOV) United States $0.469B 0.00
Health Catalyst (HCAT) United States $0.400B 0.00
Pulmonx (LUNG) United States $0.362B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.303B 0.00
Butterfly Network (BFLY) United States $0.219B 0.00
P3 Health Partners (PIII) United States $0.194B 0.00
Outset Medical (OM) United States $0.184B 0.00
American Well (AMWL) United States $0.142B 0.00
TruBridge (TBRG) United States $0.134B 7.22
MSP Recovery (LIFW) United States $0.111B 0.00
111 (YI) China $0.109B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.072B 0.00
SHL Telemedicine (SHLT) Israel $0.072B 0.00
Future Health ESG (FHLT) United States $0.068B 0.00
Augmedix (AUGX) United States $0.058B 0.00
EUDA Health Holdings (EUDA) Singapore $0.058B 0.00
HeartBeam (BEAT) United States $0.057B 0.00
Zepp Health (ZEPP) China $0.052B 0.00
Movano (MOVE) United States $0.046B 0.00
CareCloud (CCLD) United States $0.036B 0.00
Akili (AKLI) United States $0.034B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.030B 0.00
Bullfrog AI Holdings (BFRG) United States $0.024B 0.00
Streamline Health Solutions (STRM) United States $0.019B 0.00
Cue Health (HLTH) United States $0.018B 0.00
Strata Skin Sciences (SSKN) United States $0.015B 0.00
Syra Health (SYRA) United States $0.011B 0.00
Biotricity (BTCY) United States $0.011B 0.00
Transgenomic (PRPO) United States $0.009B 0.00
Predictive Oncology (POAI) United States $0.007B 0.00
HeartSciences (HSCS) United States $0.006B 0.00
Healthcare Triangle (HCTI) United States $0.004B 0.00
Zhongchao (ZCMD) China $0.003B 0.00
Tivic Health Systems (TIVC) United States $0.001B 0.00
Centogene (CNTG) Germany $0.000B 0.00
MDxHealth SA (MDXH) Belgium $0.000B 0.00
Nyxoah SA (NYXH) Belgium $0.000B 0.00